FI881103A - Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi - Google Patents
Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI881103A FI881103A FI881103A FI881103A FI881103A FI 881103 A FI881103 A FI 881103A FI 881103 A FI881103 A FI 881103A FI 881103 A FI881103 A FI 881103A FI 881103 A FI881103 A FI 881103A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- antidiabetic agents
- benzoxazole derivatives
- benzoxazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6535987 | 1987-03-18 | ||
JP6535987 | 1987-03-18 | ||
JP6707387 | 1987-03-20 | ||
JP6707387 | 1987-03-20 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI881103A0 FI881103A0 (fi) | 1988-03-09 |
FI881103A true FI881103A (fi) | 1988-09-19 |
FI91869B FI91869B (fi) | 1994-05-13 |
FI91869C FI91869C (fi) | 1994-08-25 |
Family
ID=26406503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI881103A FI91869C (fi) | 1987-03-18 | 1988-03-09 | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi |
Country Status (15)
Country | Link |
---|---|
US (2) | US4897393A (fi) |
EP (1) | EP0283035B1 (fi) |
KR (1) | KR930008450B1 (fi) |
CN (1) | CN1026322C (fi) |
AU (2) | AU600805B2 (fi) |
CA (1) | CA1304371C (fi) |
DE (1) | DE3865988D1 (fi) |
DK (1) | DK147488A (fi) |
ES (1) | ES2037752T3 (fi) |
FI (1) | FI91869C (fi) |
FR (1) | FR2612516B1 (fi) |
GR (1) | GR3003070T3 (fi) |
HU (2) | HU204525B (fi) |
IE (1) | IE59335B1 (fi) |
IL (1) | IL85767A (fi) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU210339B (en) * | 1985-05-21 | 1995-03-28 | Pfizer | Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect |
FI91869C (fi) * | 1987-03-18 | 1994-08-25 | Tanabe Seiyaku Co | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi |
JPS63230689A (ja) * | 1987-03-18 | 1988-09-27 | Tanabe Seiyaku Co Ltd | ベンゾオキサジン誘導体 |
JPH02167224A (ja) * | 1988-09-13 | 1990-06-27 | Tanabe Seiyaku Co Ltd | 抗脂血剤 |
JPH03173874A (ja) * | 1989-09-29 | 1991-07-29 | Mitsubishi Kasei Corp | 新規複素環化合物 |
WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
US5037842A (en) * | 1990-06-05 | 1991-08-06 | Pfizer Inc. | Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents |
US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
JPH04210683A (ja) * | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
US5158966A (en) * | 1991-02-22 | 1992-10-27 | The University Of Colorado Foundation, Inc. | Method of treating type i diabetes |
ATE142631T1 (de) * | 1991-06-25 | 1996-09-15 | Pfizer | Thiazolidindione als hypoglykämische wirkstoffe |
TW222626B (fi) * | 1991-07-22 | 1994-04-21 | Pfizer | |
EP0535269A1 (en) * | 1991-10-04 | 1993-04-07 | Tanabe Seiyaku Co., Ltd. | Pharmaceutical compositions containing thiazolidinedione derivatives |
US5498621A (en) * | 1992-05-01 | 1996-03-12 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
ZA936492B (en) * | 1992-09-10 | 1995-03-02 | Lilly Co Eli | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease. |
US5594016A (en) * | 1992-12-28 | 1997-01-14 | Mitsubishi Chemical Corporation | Naphthalene derivatives |
JP2845743B2 (ja) * | 1992-12-28 | 1999-01-13 | 三菱化学株式会社 | 新規なナフタレン誘導体 |
US6046222A (en) * | 1993-09-15 | 2000-04-04 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
US5401761A (en) * | 1993-12-09 | 1995-03-28 | Pfizer, Inc. | Thiazolidinedione hypoglycemic agents |
US6251928B1 (en) | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
US5708012A (en) * | 1995-04-28 | 1998-01-13 | Sankyo Company, Limited | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus |
HUP9601808A3 (en) * | 1995-07-03 | 2000-06-28 | Sankyo Co | Treatment of arteriosclerosis and xanthoma |
US5860902A (en) * | 1996-02-09 | 1999-01-19 | Jang; Bor-Zeng Bohr | Paint roller frame with an adjustable handle |
CA2257284C (en) * | 1996-05-31 | 2005-10-04 | Sankyo Company Limited | Remedy for autoimmune diseases |
JP2001514663A (ja) * | 1997-03-12 | 2001-09-11 | エスモンド,ロバート ダブリュー. | アルツハイマー病を処置または予防するための方法 |
HUP9902721A2 (hu) | 1997-11-25 | 1999-12-28 | The Procter & Gamble Co. | Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület |
US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
CA2350599A1 (en) * | 1998-11-20 | 2000-06-02 | Genentech, Inc. | Method of inhibiting angiogenesis |
US6191154B1 (en) | 1998-11-27 | 2001-02-20 | Case Western Reserve University | Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases |
US6756360B1 (en) | 1998-12-24 | 2004-06-29 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
JP2001072592A (ja) | 1999-07-01 | 2001-03-21 | Kyowa Hakko Kogyo Co Ltd | テロメラーゼ阻害剤 |
NZ517993A (en) | 1999-08-31 | 2004-03-26 | Incyte San Diego Inc | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
CO5261573A1 (es) | 1999-11-19 | 2003-03-31 | Novartis Ag | Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion |
US6784199B2 (en) | 2000-09-21 | 2004-08-31 | Aryx Therapeutics | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals |
US6680387B2 (en) * | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US6958355B2 (en) * | 2000-04-24 | 2005-10-25 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US20110212054A1 (en) * | 2000-05-25 | 2011-09-01 | Glaxosmithkline Llc. | Thrombopoietin mimetics |
CY2010012I2 (el) * | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
US6452014B1 (en) * | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
WO2002051441A1 (fr) * | 2000-12-26 | 2002-07-04 | Sankyo Company, Limited | Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline |
MXPA03008117A (es) * | 2001-03-07 | 2004-11-12 | Incyte San Diego Inc | Derivados heterociclicos para el tratamiento del cancer y otras enfermedades proliferativas. |
EP1377559A4 (en) * | 2001-03-08 | 2005-09-28 | Incyte San Diego Inc | MOLECULES ACTIVATING AN RXR RECEPTOR |
US6660858B2 (en) | 2001-03-28 | 2003-12-09 | Lion Bioscience Ag | 2-aminobenzoxazole derivatives and combinatorial libraries thereof |
US20060047000A1 (en) * | 2001-04-24 | 2006-03-02 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US20050119314A1 (en) * | 2002-04-05 | 2005-06-02 | Sankyo Company, Limited | Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent |
TWI280128B (en) * | 2002-05-22 | 2007-05-01 | Smithkline Beecham Corp | 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
US7414040B2 (en) * | 2002-06-06 | 2008-08-19 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
US7230016B2 (en) | 2003-05-13 | 2007-06-12 | Synthon Ip Inc. | Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
DE10331675A1 (de) * | 2003-07-14 | 2005-02-10 | Bayer Cropscience Ag | Hetarylsubstituierte Pyrazolidindion-Derivate |
TW200526638A (en) * | 2003-10-22 | 2005-08-16 | Smithkline Beecham Corp | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
WO2005080387A2 (en) | 2004-02-20 | 2005-09-01 | Synthon B.V. | Processes for making pioglitazone and compounds of the processes |
WO2005100331A2 (en) * | 2004-04-14 | 2005-10-27 | Ranbaxy Laboratories Limited | Antidiabetic agents |
US20080093981A1 (en) * | 2004-08-23 | 2008-04-24 | Semiconductor Energy Laboratory Co., Ltd. | Electron Injecting Composition, and Light Emitting Element and Light Emitting Device Using the Electron Injecting Composition |
ECSP077628A (es) * | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
BRPI1014548A2 (pt) | 2009-05-29 | 2015-08-25 | Glaxosmithkline Llc | Métodos de administração de compostos agonistas de trombopoetina |
US9623015B2 (en) | 2012-11-05 | 2017-04-18 | Commissariat À L'energie Atomique Et Aux Energies Alternatives (Cea) | Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse |
US9246108B2 (en) | 2012-12-28 | 2016-01-26 | Dow Global Technologies Llc | Quinoline-benzoxazole derived compounds for electronic films and devices |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58118577A (ja) * | 1982-01-07 | 1983-07-14 | Takeda Chem Ind Ltd | チアゾリジン誘導体 |
CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物,其制备方法和用途 |
AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
HU210339B (en) * | 1985-05-21 | 1995-03-28 | Pfizer | Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect |
JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
JPS6212776A (ja) * | 1985-07-10 | 1987-01-21 | Taiho Yakuhin Kogyo Kk | ロ−ダニン誘導体 |
FI91869C (fi) * | 1987-03-18 | 1994-08-25 | Tanabe Seiyaku Co | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi |
GB8713861D0 (en) * | 1987-06-13 | 1987-07-15 | Beecham Group Plc | Compounds |
IE940525L (en) * | 1988-05-25 | 1989-11-25 | Warner Lambert Co | Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents |
CA2013599C (en) * | 1989-04-07 | 1999-11-16 | Jill A. Panetta | Aryl-substituted rhodanine derivatives |
-
1988
- 1988-03-09 FI FI881103A patent/FI91869C/fi not_active IP Right Cessation
- 1988-03-14 US US07/167,391 patent/US4897393A/en not_active Expired - Fee Related
- 1988-03-16 IE IE77188A patent/IE59335B1/en not_active IP Right Cessation
- 1988-03-16 CA CA000561556A patent/CA1304371C/en not_active Expired - Fee Related
- 1988-03-16 AU AU13177/88A patent/AU600805B2/en not_active Ceased
- 1988-03-17 CN CN88101542A patent/CN1026322C/zh not_active Expired - Fee Related
- 1988-03-17 HU HU881317A patent/HU204525B/hu not_active IP Right Cessation
- 1988-03-17 KR KR1019880002824A patent/KR930008450B1/ko not_active IP Right Cessation
- 1988-03-17 IL IL85767A patent/IL85767A/xx not_active IP Right Cessation
- 1988-03-17 DK DK147488A patent/DK147488A/da not_active Application Discontinuation
- 1988-03-18 EP EP88104361A patent/EP0283035B1/en not_active Expired - Lifetime
- 1988-03-18 ES ES198888104361T patent/ES2037752T3/es not_active Expired - Lifetime
- 1988-03-18 FR FR8803570A patent/FR2612516B1/fr not_active Expired - Fee Related
- 1988-03-18 DE DE8888104361T patent/DE3865988D1/de not_active Expired - Fee Related
-
1989
- 1989-11-13 US US07/435,807 patent/US4948900A/en not_active Expired - Fee Related
-
1990
- 1990-05-21 AU AU55783/90A patent/AU618483B2/en not_active Ceased
-
1991
- 1991-11-07 GR GR91401153T patent/GR3003070T3/el unknown
-
1995
- 1995-06-29 HU HU95P/P00601P patent/HU211959A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
FR2612516A1 (fr) | 1988-09-23 |
DE3865988D1 (de) | 1991-12-12 |
AU1317788A (en) | 1988-09-22 |
AU618483B2 (en) | 1991-12-19 |
ES2037752T3 (es) | 1993-07-01 |
IL85767A0 (en) | 1988-09-30 |
US4948900A (en) | 1990-08-14 |
CN88101542A (zh) | 1988-10-05 |
FR2612516B1 (fr) | 1992-11-13 |
US4897393A (en) | 1990-01-30 |
EP0283035B1 (en) | 1991-11-06 |
HU211959A9 (en) | 1996-01-29 |
DK147488D0 (da) | 1988-03-17 |
GR3003070T3 (en) | 1993-02-17 |
HUT50339A (en) | 1990-01-29 |
EP0283035A1 (en) | 1988-09-21 |
HU204525B (en) | 1992-01-28 |
FI881103A0 (fi) | 1988-03-09 |
IE880771L (en) | 1988-09-18 |
FI91869B (fi) | 1994-05-13 |
DK147488A (da) | 1988-09-19 |
IE59335B1 (en) | 1994-02-09 |
AU600805B2 (en) | 1990-08-23 |
AU5578390A (en) | 1990-10-11 |
FI91869C (fi) | 1994-08-25 |
KR930008450B1 (ko) | 1993-09-04 |
KR880011153A (ko) | 1988-10-26 |
CA1304371C (en) | 1992-06-30 |
IL85767A (en) | 1993-08-18 |
CN1026322C (zh) | 1994-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI881103A (fi) | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi | |
FI890282A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
PT87754A (pt) | Process for the preparation of new amino acid derivatives | |
FI92934B (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi | |
FI871492A (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi | |
FI874459A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi | |
FI873350A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
FI93106C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi | |
FI902316A0 (fi) | Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä | |
FI884660A (fi) | Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi | |
FI895983A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi | |
FI93107B (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-imino-6-polyfluorialkoksibentsotiatsolijohdannaisten valmistamiseksi | |
FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
IS3589A7 (is) | Aðferð við framleiðslu á efnasambandinu Indenoindoles I | |
FI901606A0 (fi) | Tieno-triatsolo-diatsepiinien sulfonyylijohdosten valmistusmenetelmä | |
FI900145A0 (fi) | Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi | |
PT88158A (pt) | Process for the preparation of a novel diosmin derivative | |
FI891111A0 (fi) | Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
FI93216C (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi | |
FI892144A0 (fi) | Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi | |
FI93442B (fi) | Menetelmä uusien kysteiinijohdannaisten valmistamiseksi | |
FI93725B (fi) | Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi | |
FI93008B (fi) | Menetelmä bakteerien vastaisten 6-fluori-1,4-dihydrokinol-4-oni-3-karboksyylihappojohdannaisten valmistamiseksi | |
FI893121A0 (fi) | Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi | |
FI871479A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed |
Owner name: TANABE SEIYAKU CO., . LTD. |